Duke Gets Grant For HIV Resistance Study | Bill & Melinda Gates Foundation

DURHAM, N.C. -- Duke University has received a two-year, $3 million grant from the Bill & Melinda Gates Foundation to study resistance to HIV infection among people with hemophilia.
 
The study, to be conducted at the Center for Human Genome Variation at Duke’s Institute for Genome Sciences & Policy, will build upon a growing body of evidence that may help explain why some people are able to fend off infection, even when repeatedly exposed to HIV, a phenomenon known as host resistance.  Center Director David Goldstein, PhD, will lead the investigation in collaboration with Kevin Shianna, PhD, and Jacques Fellay, M.D., PhD.

To read the full press release, visit the MyNC.com web site.